{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:26:45Z","timestamp":1770330405728,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.ejphar.2009.10.040","type":"journal-article","created":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T14:43:06Z","timestamp":1256654586000},"page":"325-331","source":"Crossref","is-referenced-by-count":14,"title":["Clinical implications of the type 1\/type 2 balance of helper T cells and P-glycoprotein function in peripheral T lymphocytes of myasthenia gravis patients"],"prefix":"10.1016","volume":"627","author":[{"given":"Masayuki","family":"Masuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Ido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Utsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.10.040_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/clin.1993.1071","article-title":"Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis","volume":"67","author":"Asthana","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2009.10.040_bib4","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","article-title":"Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity","volume":"33","author":"Besinger","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2009.10.040_bib5","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.4049\/jimmunol.158.12.5589","article-title":"Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes","volume":"158","author":"Blotta","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib6","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI113807","article-title":"In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes","volume":"82","author":"Brocke","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2009.10.040_bib7","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood.V80.11.2735.bloodjournal80112735","article-title":"Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes","volume":"80","author":"Chaudhary","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2009.10.040_bib8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archneur.64.12.1792","article-title":"Immunosuppressive or surgical treatment for ocular myasthenia gravis","volume":"64","author":"Chavis","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib9","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1073\/pnas.0400339101","article-title":"Interleukin 2 plays a central role in Th2 differentiation","volume":"101","author":"Cote-Sierra","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2009.10.040_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cyto.a.10114","article-title":"Measurement of basal, substrate induced and total P-glycoprotein activity in bronchoalveolar lavage T-cell subsets","volume":"57","author":"Donnenberg","year":"2004","journal-title":"Cytometry A"},{"key":"10.1016\/j.ejphar.2009.10.040_bib11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood.V88.5.1747.1747","article-title":"Involvement of P-glycoprotein in the transmembrane transport of interleukin-2(IL-2), IL-4, and interferon-gamma in normal human T lymphocytes","volume":"88","author":"Drach","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2009.10.040_bib12","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.4049\/jimmunol.164.12.6105","article-title":"Altered composition of the immunological synapse in an anergic, age-dependent memory T cell subset","volume":"164","author":"Eisenbraun","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib13","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.4049\/jimmunol.141.10.3361","article-title":"Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis","volume":"141","author":"Fujii","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib14","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2009.10.040_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1096\/fasebj.8.6.7513288","article-title":"Immunophilins in protein folding and immunosuppression","volume":"8","author":"Fruman","year":"1994","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2009.10.040_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/jpet.106.110155","article-title":"Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody","volume":"320","author":"Goda","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.10.040_bib17","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI113729","article-title":"Ajuxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis","volume":"82","author":"Harcourt","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2009.10.040_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0009-9236(98)90042-X","article-title":"Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis","volume":"63","author":"Hirano","year":"1998","journal-title":"Clin. Pharmcol. Ther."},{"key":"10.1016\/j.ejphar.2009.10.040_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/0091270004264162","article-title":"MDR1 mRNA expressions in peripheral blood mononuclear cells of patients with ulcerative colitis in relation to glucocorticoid administration","volume":"44","author":"Hirano","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.179.1.305","article-title":"Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB\/W mice","volume":"179","author":"Ishida","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2009.10.040_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2009.10.040_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0022-1759(93)90158-4","article-title":"Detection of intracellular cytokines by flow cytometry","volume":"159","author":"Jung","year":"1993","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejphar.2009.10.040_bib23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.172.3.921","article-title":"Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells","volume":"172","author":"Le Gros","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2009.10.040_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/rheumatology\/35.5.430","article-title":"Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone","volume":"35","author":"Maillefert","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1097-0320(19981015)34:5<207::AID-CYTO1>3.0.CO;2-J","article-title":"Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression","volume":"34","author":"Maino","year":"1998","journal-title":"Cytometry"},{"key":"10.1016\/j.ejphar.2009.10.040_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2006.07.004","article-title":"CD4+ T and B cells cooperate in the immunoregulation of experimental autoimmune myasthenia gravis","volume":"179","author":"Milani","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib27","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/1074-7613(95)90169-8","article-title":"An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis","volume":"3","author":"Nicholson","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2009.10.040_bib30","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4049\/jimmunol.170.1.604","article-title":"Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL\/6 mice","volume":"170","author":"Ostlie","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/clin.1993.1024","article-title":"Cyclosporine, tolerance, and autoimmunity","volume":"66","author":"Prud'homme","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib32","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1084\/jem.180.5.1961","article-title":"Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease","volume":"180","author":"Racke","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2009.10.040_bib33","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.4049\/jimmunol.156.7.2406","article-title":"Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro","volume":"156","author":"Ram\u00edrez","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.immunol.15.1.707","article-title":"Transcription factors of the NFAT family: regulation and function","volume":"15","author":"Rao","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1084\/jem.178.1.87","article-title":"Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice","volume":"178","author":"Rapoport","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2009.10.040_bib36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.1348873","article-title":"Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene","volume":"256","author":"Raymond","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2009.10.040_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mus.1220","article-title":"Steroid treatment for myasthenia gravis: steroids are overutilized","volume":"25","author":"Rivner","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejphar.2009.10.040_bib38","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/S0021-9258(18)53221-X","article-title":"Human P-glycoprotein transports cyclosporin A and FK506","volume":"268","author":"Saeki","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2009.10.040_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib40","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1016\/S0021-9258(18)42611-7","article-title":"Peptide transport by the multidrug resistance pump","volume":"267","author":"Sharma","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2009.10.040_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1248\/bpb.30.291","article-title":"P-glycoprotein function in peripheral blood mononuclear cells of myasthenia gravis patients treated with tacrolimus","volume":"30","author":"Tanaka","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2009.10.040_bib42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1749-6632.1993.tb22937.x","article-title":"A clinical therapeutic trial of cyclosporine in myasthenia gravis","volume":"681","author":"Tindall","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2009.10.040_bib43","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0006-291X(86)80136-X","article-title":"The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein","volume":"141","author":"Ueda","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2009.10.040_bib44","doi-asserted-by":"crossref","first-page":"24248","DOI":"10.1016\/S0021-9258(18)35757-0","article-title":"Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone","volume":"267","author":"Ueda","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2009.10.040_bib45","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vicent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2009.10.040_bib46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0960-0760(93)90080-G","article-title":"Sex hormones and dexamethasone modulate interleukin-5 gene expression in T lymphocytes","volume":"44","author":"Wang","year":"1993","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1189\/jlb.0605328","article-title":"Critical involvement of IL-12 in IFN-gamma induction by calcineurin antagonists in activated human lymphocytes","volume":"80","author":"Wittmann","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib48","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2009.10.040_bib49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2006.05.042","article-title":"FOXP3 controls regulatory T cell function through cooperation with NFAT","volume":"126","author":"Wu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2009.10.040_bib50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2006.02.012","article-title":"Elevation of IL-12 p40 and its antibody in myasthenia gravis with thymoma","volume":"175","author":"Yoshikawa","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2009.10.040_bib51","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/25.7.894009","article-title":"Proof without prejudice: use of the Kolmogorov\u2013Smirnov test for the analysis of histograms from flow systems and other sources","volume":"25","author":"Young","year":"1977","journal-title":"J. Histochem. Cytochem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909009479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909009479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T09:16:28Z","timestamp":1685178988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299909009479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":50,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0014299909009479"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.10.040","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}